Bringing the fundamentals into focus…
Back to Organon & Co.
How Organon & Co. stacks up
OGN · against 267 other Healthcare companies of similar size
Growth
15/ 100
Near the bottom of its peers.
Ranked #237 of 268 · scores higher than 11% of peers
Bars: peers in each 10-point band of the growth score17 peers with a growth score of 10–19, including OGN · Click a bar to see the companies
Why growth scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth, revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 94% of peers. Earnings per share growth: -70.4% vs peer median 9.8%
- slower revenue growth over the last year: weaker than 75% of peers. Revenue growth: -2.5% vs peer median 6.1%
- slower revenue growth over three years: weaker than 72% of peers. 3-year revenue growth: -0.2% vs peer median 5.8%
Metric by metric
Position: dot = OGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | OGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 267 reported | -2.5% | 8.0% | 20% | 33% | |
| Earnings per share growthHigher is better · 171 reported | -70.4% | 10.9% | 2% | 33% | |
| 3-year revenue growthHigher is better · 261 reported | -0.2% | 8.7% | 23% | 33% |
Ranking by growth score
Top 5 and the companies ranked around OGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 233 | 2.0B USD | 17 | 24 | |
| 235 | 21.6B CNY (≈$3.0B) | 16 | 41 | |
| 235 | 15.6B DKK (≈$2.3B) | 16 | 33 | |
| 237 | 23.8B CNY (≈$3.3B) | 15 | 54 | |
| 237 | 3.6B USD | 15 | 43 | |
| 237 | 2.3B USD | 15 | 27 | |
| 240 | 14.0B CNY (≈$2.0B) | 14 | 40 | |
| 240 | 2.8B USD | 14 | 22 | |
| 240 | 3.0B CHF (≈$3.5B) | 14 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score